Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 17Unknown 6Terminated 3Recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Stomatitis 1Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX 1Mucositis 1

Interventions

pembrolizumab 223Carboplatin 222Specimen Handling 194Cisplatin 192Magnetic Resonance Spectroscopy 165Radiotherapy 153Bevacizumab 143Gemcitabine 136Cyclophosphamide 135Drug Therapy 119Capecitabine 118Paclitaxel 116Oxaliplatin 111Nivolumab 105Biopsy 104venetoclax 103tislelizumab 83Rituximab 83durvalumab 82toripalimab 78Fluorouracil 73Etoposide 72Docetaxel 69Dexamethasone 69sintilimab 67Pemetrexed 67atezolizumab 65Radiosurgery 65Azacitidine 63130-nm albumin-bound paclitaxel 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Folic Acid × Clear all
NCT03581773 2026-05-04

DARENCA4

University of Aarhus

Phase 2 Recruiting
100 enrolled
Other

Stomatitis, Mucositis

NCT05378919 2022-05-18

RECTUM2015

Lithuanian University of Health Sciences

Phase 2 Recruiting
250 enrolled
Gastrointestinal

Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX

Data powered by HemOnc (CC BY 4.0) Colophon âš¡